Pharmacists in Pottsboro, TX Accepting Medicare
7 Pharmacists found. Showing 1 - 7
 Arwinder Gill Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11205 N State Hwy 289, Pottsboro, TX 75076 Phone: 903-786-3025 |
 Steven Michael Fairchild Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11205 N. Hwy 289, Pottsboro, TX 75076 Phone: 903-786-3150 |
Akosua Gyankoma Boateng Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11205 N Highway 289, Pottsboro, TX 75076 Phone: 903-786-3150 |
Dr. Susan Renee Morrison-peippo, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 111 E Hwy 120 Ste 101, Pottsboro, TX 75076 Phone: 903-786-2006 Fax: 903-355-2361 |
Mrs. Debra Ann Sparlin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 563 W Fm 120, Pottsboro, TX 75076 Phone: 903-768-2006 |
Mr. Mark Frederick Peippo, RPH Pharmacist Medicare: Medicare Enrolled Practice Location: 563 W Fm 120, Pottsboro, TX 75076 Phone: 903-786-2006 Fax: 903-355-2361 |
Lauren Ashley Black, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11205 N. Hwy 289, Pottsboro, TX 75076 Phone: 903-786-3150 |
News Archive
Idaho ‘pushing envelope' with health insurance plan. Can it do that?
For the past year, the Trump administration and Republicans in Congress have led a charge to roll back the Affordable Care Act, signaling an openness to state changes.
Fenwal receives FDA marketing clearance for Amicus blood cell separator
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.
Positive impact on medication adherence through Aetna's care management program
Aetna announced today results of an analysis from the first half of 2009, demonstrating an average medication adherence of over 95 percent for its members taking Specialty medications. Disease states evaluated in Aetna's analysis include: multiple sclerosis, rheumatoid arthritis, HIV, Crohn's disease, Pulmonary Arterial Hypertension (PAH), psoriasis, Hepatitis C and asthma.
Herceptin and chemotherapy improves response rates without major adverse effects in HER2 breast cancer
Women with a particularly aggressive form of breast cancer seem to do better if they are treated with a combined anthracycline and taxane chemotherapy regimen before surgery, together with trastuzumab (Herceptin) before and after surgery, according to results from the largest multi-centre trial to investigate this treatment.
› Verified 4 days ago